L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: A prospective, placebo controlled, randomised, pilot study.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2011
At a glance
- Drugs Arginine (Primary) ; Drospirenone/ethinylestradiol (Primary)
- Indications Cardiovascular disorders; Polycystic ovary syndrome
- Focus Adverse reactions; Therapeutic Use
- 09 Mar 2011 New trial record